REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/13/2025
Back to search
Official data from USPTO
CLINIQUE PEP START
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINIQUE PEP START
ST13
US500000086504131Class
3
Filing
86504131
Registration
5041951
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
09/14/2025
Trademark type
Word
Nice classes
3
Filing date
01/15/2015
Registration date
09/13/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/07/2023
Last transaction
09/14/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/31/2016
First use in commerce
01/31/2016
Drawing code
4
Owner type
16
Owner location
New York, NY
Examiner
MCMORROW, RONALD
Law office
M90
Current location
TMO LAW OFFICE 118
Holders and representatives
Holders
Clinique Laboratories, LLC
Representatives
Derek Morales The Estee Lauder Companies Inc.
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetics; non-medicated skin care preparations; non-medicated toiletries
Publications
History of USPTO decisions and trademark events.
31 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/07/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/07/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/07/2023
E815
TEAS SECTION 8 & 15 RECEIVED
08/19/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/13/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/13/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/12/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/11/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/06/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/05/2016
EX2G
SOU EXTENSION 2 GRANTED
08/05/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/29/2016
EXT2
SOU EXTENSION 2 FILED
06/29/2016
IUAF
USE AMENDMENT FILED
06/29/2016
EEXT
SOU TEAS EXTENSION RECEIVED
06/29/2016
EISU
TEAS STATEMENT OF USE RECEIVED
06/29/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/09/2016
EX1G
SOU EXTENSION 1 GRANTED
01/07/2016
EXT1
SOU EXTENSION 1 FILED
01/07/2016
EEXT
SOU TEAS EXTENSION RECEIVED
01/07/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/07/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/12/2015
PUBO
PUBLISHED FOR OPPOSITION
05/12/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/22/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/03/2015
ALIE
ASSIGNED TO LIE
04/03/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/13/2015
DOCK
ASSIGNED TO EXAMINER
03/13/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/28/2015
NWAP
NEW APPLICATION ENTERED
01/19/2015
Continuous trademark protection
Get notified about every new filing that threatens CLINIQUE PEP START or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.